Dormosedan (Detomidine) is filed as Alpha-2 adrenergic agonist (sedative). The sections below restate public label fields stored for this profile.
Sedation and analgesia for diagnostic and minor surgical procedures in horses Standing chemical restraint
Activates alpha-2 adrenergic receptors in the central nervous system, producing dose-dependent sedation, analgesia, and muscle relaxation.
Monitor heart rate. Allow horse to stand quietly after administration. Do not use in horses with cardiac disease. Potentiates other CNS depressants.
Specific contraindication data for this veterinary product may not be available in public databases. Consult your veterinarian before use.
Bradycardia (Common); Reduced GI motility (Common); Sweating (Occasional); Ataxia (Common)
IV or IM injection, or sublingual gel (Dormosedan Gel). Dose based on desired level of sedation.
Limited structured drug interaction data is available from public sources for this veterinary product. Consult your veterinarian about potential interactions with other medications.
According to its FDA label, Dormosedan (Detomidine) is approved for: Sedation and analgesia for diagnostic and minor surgical procedures in horses. Standing chemical restraint For medical advice, please talk to your prescriber or pharmacist.
Dormosedan (Detomidine) belongs to the Alpha-2 adrenergic agonist (sedative) class of medications.
Not yet. As of the most recent FDA data we ingest, no A-rated generic equivalent is listed for Dormosedan. Availability changes as patents expire.
Our ingest of the FDA label for Dormosedan (Detomidine) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Dormosedan (Detomidine) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Dormosedan (Detomidine) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA label lists Zoetis as a labeler/manufacturer of Dormosedan (Detomidine). Multiple firms may market generics of the same molecule.
The FDA label states: "Store at controlled room temperature." Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…